OPKO HEALTH INC (OPK)

US68375N1037 - Common Stock

1.48  +0.03 (+2.07%)

After market: 1.48 0 (0%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to OPK. OPK was compared to 107 industry peers in the Health Care Providers & Services industry. OPK scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. OPK has a expensive valuation and it also scores bad on growth.



Quickly go to:

1

1. Profitability

1.1 Basic Checks

OPK had negative earnings in the past year.
OPK had a negative operating cash flow in the past year.
OPK had negative earnings in 4 of the past 5 years.
In multiple years OPK reported negative operating cash flow during the last 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -5.93%, OPK is doing worse than 65.71% of the companies in the same industry.
OPK's Return On Equity of -9.53% is in line compared to the rest of the industry. OPK outperforms 41.90% of its industry peers.
Industry RankSector Rank
ROA -5.93%
ROE -9.53%
ROIC N/A
ROA(3y)-8.6%
ROA(5y)-7.64%
ROE(3y)-12.14%
ROE(5y)-10.82%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

OPK has a Gross Margin (25.10%) which is in line with its industry peers.
OPK's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for OPK so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 25.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-1.1%

More info and screens

4

2. Health

2.1 Basic Checks

OPK does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for OPK remains at a similar level compared to 1 year ago.
The number of shares outstanding for OPK has been increased compared to 5 years ago.
Compared to 1 year ago, OPK has a worse debt to assets ratio.

2.2 Solvency

Based on the Altman-Z score of -0.49, we must say that OPK is in the distress zone and has some risk of bankruptcy.
OPK has a worse Altman-Z score (-0.49) than 79.05% of its industry peers.
OPK has a Debt/Equity ratio of 0.31. This is a healthy value indicating a solid balance between debt and equity.
OPK has a better Debt to Equity ratio (0.31) than 63.81% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z -0.49
ROIC/WACCN/A
WACC7.81%

2.3 Liquidity

OPK has a Current Ratio of 2.97. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
OPK has a better Current ratio (2.97) than 87.62% of its industry peers.
OPK has a Quick Ratio of 2.69. This indicates that OPK is financially healthy and has no problem in meeting its short term obligations.
OPK's Quick ratio of 2.69 is amongst the best of the industry. OPK outperforms 85.71% of its industry peers.
Industry RankSector Rank
Current Ratio 2.97
Quick Ratio 2.69

More info and screens

1

3. Growth

3.1 Past

OPK shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -16.51%.
OPK shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -17.94%.
The Revenue has been decreasing by -2.70% on average over the past years.
EPS 1Y (TTM)-16.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
Revenue 1Y (TTM)-17.94%
Revenue growth 3Y-15.58%
Revenue growth 5Y-2.7%
Sales Q2Q%-32.1%

3.2 Future

The Earnings Per Share is expected to grow by 15.69% on average over the next years. This is quite good.
The Revenue is expected to decrease by -5.11% on average over the next years.
EPS Next Y24.48%
EPS Next 2Y-8.79%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue Next Year-20.28%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.11%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

OPK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for OPK. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as OPK's earnings are expected to grow with 15.69% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-8.79%
EPS Next 3Y15.69%

More info and screens

0

5. Dividend

5.1 Amount

OPK does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

OPKO HEALTH INC

NASDAQ:OPK (1/3/2025, 8:00:02 PM)

After market: 1.48 0 (0%)

1.48

+0.03 (+2.07%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)N/A N/A
Inst Owners27.24%
Inst Owner Change2.89%
Ins Owners6.08%
Ins Owner Change6.24%
Market Cap1.01B
Analysts86
Price Target4.04 (172.97%)
Short Float %27.3%
Short Ratio19.94
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)47.05%
Min EPS beat(2)4.52%
Max EPS beat(2)89.58%
EPS beat(4)2
Avg EPS beat(4)16.94%
Min EPS beat(4)-25.07%
Max EPS beat(4)89.58%
EPS beat(8)5
Avg EPS beat(8)25.12%
EPS beat(12)5
Avg EPS beat(12)-178.95%
EPS beat(16)8
Avg EPS beat(16)-136.34%
Revenue beat(2)0
Avg Revenue beat(2)-18.22%
Min Revenue beat(2)-33.85%
Max Revenue beat(2)-2.6%
Revenue beat(4)1
Avg Revenue beat(4)-10.26%
Min Revenue beat(4)-33.85%
Max Revenue beat(4)1.44%
Revenue beat(8)5
Avg Revenue beat(8)2.62%
Revenue beat(12)6
Avg Revenue beat(12)2.52%
Revenue beat(16)9
Avg Revenue beat(16)4.51%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)7.7%
EPS NY rev (1m)10.68%
EPS NY rev (3m)39.01%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-21.99%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-2.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.42
P/FCF N/A
P/OCF N/A
P/B 0.72
P/tB 32.42
EV/EBITDA N/A
EPS(TTM)-0.31
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.29
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.04
BVpS2.06
TBVpS0.05
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -5.93%
ROE -9.53%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 25.1%
FCFM N/A
ROA(3y)-8.6%
ROA(5y)-7.64%
ROE(3y)-12.14%
ROE(5y)-10.82%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-1.1%
F-Score2
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 22.54%
Cap/Sales 3.17%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.97
Quick Ratio 2.69
Altman-Z -0.49
F-Score2
WACC7.81%
ROIC/WACCN/A
Cap/Depr(3y)26.33%
Cap/Depr(5y)26.4%
Cap/Sales(3y)2.05%
Cap/Sales(5y)1.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-16.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%18.18%
EPS Next Y24.48%
EPS Next 2Y-8.79%
EPS Next 3Y15.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-17.94%
Revenue growth 3Y-15.58%
Revenue growth 5Y-2.7%
Sales Q2Q%-32.1%
Revenue Next Year-20.28%
Revenue Next 2Y-10.71%
Revenue Next 3Y-5.11%
Revenue Next 5YN/A
EBIT growth 1Y-111.24%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year46.84%
EBIT Next 3Y32.64%
EBIT Next 5YN/A
FCF growth 1Y-112.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-155.96%
OCF growth 3YN/A
OCF growth 5YN/A